UK in first for human heart valve grown from stem cells:
This article was originally published in Clinica
Executive Summary
A UK team has created what is claimed to be the first human heart valve to be grown from stem cells. The investigators, from the Harefield Heart Science Centre near London, first used chemical and physical nudges to coax stem cells extracted from bone marrow to grow into heart valve cells, according to an article published in The Guardian (April 2). The cells were then placed on collagen scaffolds and grown into 3cm-wide discs of heart valve tissue. The valves are expected to be tested in animals later this year. In a comment by the British Heart Foundation, Professor John Martin said: "Although the work carried out the Harefield is exciting, there is a long road to be travelled before patients awaiting heart transplants will benefit from this research."
You may also be interested in...
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.
China’s Public Payer Wants To Define Innovative Drugs As Those With ‘Novel Benefits’
China’s public payer perceives innovative drugs in a different way from that of the country’s top drug regulator, a former senior healthcare security official with knowledge of the matter reveals. The posture has unnerved pharma companies, which have been hit by sharp price discounts.
Change Is Constant For Pneumococcal Vaccines: US CDC Prepares For Merck’s V116
As Merck’s 21-valent vaccine approaches its 17 June user fee goal, the US CDC’s vaccine committee is looking at new adult age-based recommendations and bracing for a full pipeline led by GSK’s 24-valent candidate.